Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Karl Mahler, Executive. Director active across 1 company, notably Marinomed Biotech AG. Aggregated, 2 filings have been recorded. Activity tracked since 8 January 2025. The latest transaction was filed on 31 March 2026 (Other). Regulator: FMA (OeKB OAM). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Karl Mahler is an Executive at Marinomed Biotech AG. In this role, he is involved in the strategic management of the company and contributes to key decision-making. His experience in the biopharmaceutical sector allows him to play a crucial role in the direction and growth of Marinomed. Karl is committed to promoting sustainable and responsible practices.